SCHEMBL16628495

SCHEMBL16628495

O=P(c1ccccc1)(c1cccc(-c2ccc3ccc4cccc5ccc2c3c45)c1)c1cccc(-c2ccc3ccc4cccc5ccc2c3c45)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.40
ERBB2 P04626 1/20 0.40
FYN P06241 1/20 0.40
MAOA P21397 1/20 0.40
ACHE P22303 1/20 0.40
AHR P35869 1/20 0.40
ALDH1A1 P00352 5/20 0.35
HPGD P15428 5/20 0.35
HSD17B10 Q99714 4/20 0.35
THRB P10828 1/20 0.35
CYP3A4 P08684 2/20 0.35
TSHR P16473 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP19A1 P11511 1/20 0.34
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30892134 1.00 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL16628537 1.00 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL29449982 1.00 CYP1A2 (0.40) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18133325 0.97 CYP1A2 (0.38) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL31286417 0.97 CYP1A2 (0.38) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18123662 0.97 CYP1A2 (0.38) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL18133329 0.96 CYP1A2 (0.37) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL31286414 0.96 CYP1A2 (0.37) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL24470164 0.95 TOP1 (0.34) CYP1A2ERBB2FYNMAOAACHE
SCHEMBL29662068 0.94 CYP1A2 (0.38) CYP1A2ERBB2FYNMAOAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3195381-B1 ORGANIC LIGHT-EMITTING DIODE INCLUDING AN ELECTRON TRANSPORT LAYER STACK COMPRISING DIFFERENT LITHIUM COMPOUNDS AND ELEMENTAL METAL NOVALED GMBH (DE) 2024-09-11 EP claimed
EP-3235019-B1 ORGANIC LIGHT-EMITTING DIODE COMPRISING ELECTRON TRANSPORT LAYERS WITH DIFFERENT MATRIX COMPOUNDS NOVALED GMBH (DE) 2022-10-05 EP claimed
EP-3294727-B1 ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER NOVALED GMBH (DE) 2021-08-04 EP claimed
EP-3164898-B1 ORGANIC LIGHT-EMITTING DIODE (OLED) INCLUDING AN ELECTRON TRANSPORT LAYER STACK COMPRISING DIFFERENT LITHIUM COMPOUNDS NOVALED GMBH (DE) 2021-05-12 EP claimed
EP-3147962-B1 ORGANIC ELECTROLUMINESCENT DEVICE NOVALED GMBH (DE) 2021-04-21 EP claimed
US-10910581-B2 Organic light-emitting diode comprising electron transport layers with different matrix compounds NOVALED GMBH (DE) 2021-02-02 US claimed
US-10700300-B2 Organic light-emitting diode including an electron transport layer stack comprising different lithium compounds and elemental metal NOVALED GMBH (DE) 2020-06-30 US claimed
EP-2999019-B1 Organic light-emitting diode including an electron transport layer stack comprising different lithium compounds and elemental metal NOVALED GMBH (DE) 2019-06-12 EP claimed
US-10205107-B2 Organic light-emitting diode (OLED) including an electron transport layer stack comprising different lithium compounds NOVALED GMBH (DE) 2019-02-12 US claimed
US-20180261784-A1 Organic Light-Emitting Diode Comprising Electron Transport Layers with Different Matrix Compounds NOVALED GMBH (DE) 2018-09-13 US claimed
US-20170170411-A1 Organic Light-Emitting Diode (OLED) Including an Electron Transport Layer Stack Comprising Different Lithium Compounds NOVALED GMBH (DE) 2017-06-15 US claimed
EP-3164898-A1 ORGANIC LIGHT-EMITTING DIODE (OLED) INCLUDING AN ELECTRON TRANSPORT LAYER STACK COMPRISING DIFFERENT LITHIUM COMPOUNDS Novaled GmbH (DE) 2017-05-10 EP claimed
EP-3147961-A1 ORGANIC ELECTROLUMINESCENT DEVICE Novaled GmbH (DE) 2017-03-29 EP claimed
EP-3147962-A1 ORGANIC ELECTROLUMINESCENT DEVICE Novaled GmbH (DE) 2017-03-29 EP claimed
WO-2016180891-A1 ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER NOVALED GMBH (DE) 2016-11-17 WO claimed
EP-3093288-A1 ORGANIC LIGHT-EMITTING DIODE COMPRISING DIFFERENT MATRIX COMPOUNDS IN THE FIRST AND SECOND ELECTRON TRANSPORT LAYER Novaled GmbH (DE) 2016-11-16 EP claimed
EP-3035400-A1 Organic light-emitting diode comprising electron transport layers with different matrix compounds Novaled GmbH (DE) 2016-06-22 EP claimed
EP-3002796-A1 Organic light-emitting diode including an electron transport layer comprising a three component blend of a matrix compound and two lithium compounds Novaled GmbH (DE) 2016-04-06 EP claimed
EP-2999019-A1 Organic light-emitting diode including an electron transport layer stack comprising different lithium compounds and elemental metal Novaled GmbH (DE) 2016-03-23 EP claimed
EP-2963696-A1 Organic light-emitting diode (OLED) including an electron transport layer stack comprising different lithium compounds Novaled GmbH (DE) 2016-01-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910581-B2 Organic light-emitting diode comprising electron transport layers with different matrix compounds CLTB, SLC10A6, CYBA CYP1A2 848/4885ERBB2 3895/4885FYN 4144/4885
US-20180261784-A1 Organic Light-Emitting Diode Comprising Electron Transport Layers with Different Matrix Compounds CLTB, SLC10A6, CYBA CYP1A2 848/4885ERBB2 3895/4885FYN 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.